Drug Trial Radar · NCT05166161
A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
247
Actual
Start
Feb 14, 2022
Primary completion
Jul 21, 2026
Study completion Jul 21, 2026
Sponsor
- Lead sponsor
- PTC TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 21, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein consumption.
Conditions
- Phenylketonuria
Interventions
PTC923Drug
PTC923 powder for oral use will be suspended in water or apple juice prior to administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline up to end of study (up to 4 years)
- Change From Baseline in Dietary Phe/Protein Consumption at Week 26, Measured During Phe Tolerance Assessment PeriodTime frame: Baseline, Week 26
Locations
46 sites in 19 countries. Site status is shown where the registry gives one.
Children's Hospital Colorado
Aurora, Colorado
UF College of Medicine, Department of Pediatrics Division of Genetics and Metabolism
Gainesville, Florida
Indiana University School of Medicine Department of Medical and Molecular Genetics
Indianapolis, Indiana
Boston Children's Hospital
Boston, Massachusetts
Icahn School of Medicine at Mount Sinai (ISMMS)
New York, New York
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
University of Utah
Salt Lake City, Utah
The Queensland Children's Hospital
South Brisbane, Brisbane, Australia
Westmead Hospital
Westmead, New South Wales, Australia
PARC Clinical Research
Adelaide, South Australia, Australia
Royal Children's Hospital
Parkville, Victoria, Australia
Hospital de clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Ribeirão Preto, São Paulo, Brazil
Metabolics and Genetics in Calgary (MAGIC) Clinic, Ltd.
Calgary, Alberta, Canada
McMaster Children's Hospital Hamilton Health Sciences
Hamilton, Ontario, Canada
The Hospital for Sick Children University of Toronto Adult Clinic: The Fred A Litwin Family Centre in Genetic Medicine University Health Network & Mt. Sinai Hospital
Toronto, Ontario, Canada
Fakultní nemocnice Královské Vinohrady Klinika dětí a dorostu Ambulance pro léčbu PKU a HPA
Prague, Czechia
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
Hôpital Necker-Enfants Malades - Centre de Référence des Maladies Héréditaires du Métabolisme
Paris, France
Medical Genetics and Laboratory Diagnostics Center
Tbilisi, Georgia
University Children's Hospital Hamburg Eppendorf (Kinder-UKE) Klinik für Kinder- und Jugendmedizin (Kinder-UKE)
Hamburg, Germany
Universitätsklinikum Heidelberg / Zentrum für Kinder- und Jugendmedizin / Sektion für Neuropädiatrie & Stoffwechselmedizin
Heidelberg, Germany
Universitätsklinikum Münster
Münster, Germany
Department of Human Neuroscience, Child and Adolescent Neuropsychiatry, Policlinico Umberto I
Rome, Italy
Azienda Ospedaliera-Universita Padova
Padua, Veneto, Italy
PTC Clinical Site 1
Multiple Locations, Japan
PTC Clinical Site 2
Multiple Locations, Japan
PTC Clinical Site 3
Multiple Locations, Japan
PanAmerican Clinical Research
Guadalajara, Jalisco, Mexico
UMCG Beatrix Children's Hospital
Groningen, Netherlands
Pomorski Uniwersytet Medyczny w Szczecinie Centrum Wsparcia Badań Klinicznych
Szczecin, Poland
Centro Hospitalar Universitário Do Porto, Epe
Porto, Portugal
CENTRO HOSPITALAR UNIVERSITÁRIO LISBOA NORTE Hospital de Santa Maria,
Lisbon, Estremadura, Portugal
CENTRO HOSPITALAR UNIVERSITÁRIO LISBOA NORTE Hospital de Santa Maria
Lisbon, Estremadura, Portugal
Univerzitetni klinicni center Ljubljana
Ljubljana, Slovenia
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario Virgen del Rocío
Seville, Spain
Hospital Sant Joan de Déu
Barcelona, Esplugues de Llobregat, Spain
Çukurova Üniversitesi Tıp Fakültesi Balcalı Hastanesi
Adana, Turkey (Türkiye)
Hacettepe University Medical Faculty
Altındağ, Ankara, Turkey (Türkiye)
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.